BD Board Increases Dividend for 54th Consecutive Year
Rhea-AI Summary
BD (NYSE: BDX) declared a quarterly dividend of $1.05 per share, a 1.0% increase from the prior quarter. The dividend is payable on December 31, 2025 to holders of record on December 8, 2025.
The company set an indicated annual dividend rate for fiscal year 2026 of $4.20 per share. This marks the 54th consecutive fiscal year BD has raised its dividend, maintaining its membership in the S&P 500 Dividend Aristocrats Index. Management linked the increase to confidence in BD's long-term outlook during execution of the Waters RMT transaction.
Positive
- Dividend raised 1.0% to $1.05 per quarter
- Annualized dividend set at $4.20 for fiscal 2026
- 54 consecutive years of dividend increases (Dividend Aristocrat status)
Negative
- Modest increase of 1.0% may be below investor income expectations
News Market Reaction
On the day this news was published, BDX gained 0.57%, reflecting a mild positive market reaction. Argus tracked a trough of -4.2% from its starting point during tracking. Our momentum scanner triggered 14 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $287M to the company's valuation, bringing the market cap to $50.56B at that time.
Data tracked by StockTitan Argus on the day of publication.
"This is the 54th consecutive fiscal year in which we have raised our dividend, maintaining BD's membership in the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends for at least 25 consecutive years," said Tom Polen, chairman, CEO and president of BD. "This increase, even as we execute the Waters RMT transaction, reflects our confidence in our long-term outlook, as well as our ongoing commitment to create value and return capital to shareholders."
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
|
Contacts: |
|
|
|
|
|
Media: |
Investors: |
|
Fallon McLoughlin |
Adam Reiffe |
|
Director, Public Relations |
VP, Investor Relations |
|
201.258.0361 |
201.847.6927 |
View original content:https://www.prnewswire.com/news-releases/bd-board-increases-dividend-for-54th-consecutive-year-302606229.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
What dividend did BD (BDX) declare on November 6, 2025?
When is the BD (BDX) dividend payable and what is the record date?
What is BD's indicated annual dividend rate for fiscal year 2026?
How many consecutive years has BD (BDX) increased its dividend as of 2025?
Does BD (BDX) remain in the S&P 500 Dividend Aristocrats after the November 6, 2025 increase?
